NUVB Stock: Price, Earnings History and SEC Filings
Nuvation Bio Inc. (NUVB) last traded at $4.76, down 0.21% on the latest session and down 15.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.15 against an analyst estimate of $-0.15, a beat of 0.0%.
$4.76 -0.21%
1 month-15.00%
52-week high$9.75
52-week low$3.92
Volume5.06M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
NUVB earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.15 | $-0.15 | +0.00% |
| Mar 2026 | May 4, 2026 | $0.01 | $0.12 | -91.67% |
| Dec 2025 | Mar 2, 2026 | $-0.11 | $-0.11 | +0.00% |
| Sep 2025 | Nov 3, 2025 | $-0.16 | $-0.17 | +5.88% |
NUVB beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for NUVB
SEC filing data is not available right now. You can search for NUVB on SEC EDGAR.
NUVB news
- Nuvation Bio to Expand Pivotal Phase 3 SIGMA Study of Safusidenib for IDH1-Mutant Glioma to Six European CountriesOct 29, 2026 · finance.yahoo.com
- Nuvation Bio And 2 More Penny Stocks To WatchOct 24, 2026 · finance.yahoo.com
- Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026Oct 21, 2026 · finance.yahoo.com
About Nuvation Bio Inc.
Nuvation Bio Inc. (NUVB) is a US-listed public company on NYSE.